Schematic of the molecular mechanism underlying UA anticancer activity in NSCLC cells
A schematic of the molecular mechanism underlying UA anticancer activity in NSCLC cells. UA treatment inhibited the EGFR/JAK2/STAT3 signaling pathway, leading to the diminishment of Sox-2, Oct-4, ABCG2, CD133, and C-Myc.
Publication
Inhibitory Effect and Mechanism of Ursolic Acid on Cisplatin-Induced Resistance and Stemness in Human Lung Cancer A549 Cells (2023) Luxin Fan, et al. Evid Based Complement Alternat Med. 2023;2023(NA). Figure: F8.| Organism | Group | Word | Match | Source | NCBI Symbol | NCBI ID |
|---|
| Word | Match | MeSH | Name | ChEBI |
|---|
Disease mentions
| Word | Match | MeSH | Name | DOID |
|---|